Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TEVA-LIOTHYRONINE DIN 02494337

Status: Marketed
Holder: TEVA CANADA LIMITED
Molecule: LIOTHYRONINE (LIOTHYRONINE SODIUM)
Available to quote

Health Canada record

Active ingredient(s)LIOTHYRONINE (LIOTHYRONINE SODIUM) 5 MCG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCH03AA02 LIOTHYRONINE SODIUM
Original market date10-Jul-2020
Current status date10-Jul-2020
SourceHealth Canada DPD

Establishment licence of the holder

Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing LIOTHYRONINE (LIOTHYRONINE SODIUM)

DINProductCompanyFormStrengthStatus
02549999AURO-LIOTHYRONINEAURO PHARMA INCTabletLIOTHYRONINE (LIOTHYRONINE SODIUM) 5 MCGMarketed
02550008AURO-LIOTHYRONINEAURO PHARMA INCTabletLIOTHYRONINE (LIOTHYRONINE SODIUM) 25 MCGMarketed
01919458CYTOMELPFIZER CANADA ULCTabletLIOTHYRONINE (LIOTHYRONINE SODIUM) 5 MCGMarketed
01919466CYTOMELPFIZER CANADA ULCTabletLIOTHYRONINE (LIOTHYRONINE SODIUM) 25 MCGMarketed
02494345TEVA-LIOTHYRONINETEVA CANADA LIMITEDTabletLIOTHYRONINE (LIOTHYRONINE SODIUM) 25 MCGMarketed
02561301ZDS-LIOTHYRONINEZYDUS LIFESCIENCES LIMITEDTabletLIOTHYRONINE (LIOTHYRONINE SODIUM) 25 MCGMarketed
02561298ZDS-LIOTHYRONINEZYDUS LIFESCIENCES LIMITEDTabletLIOTHYRONINE (LIOTHYRONINE SODIUM) 5 MCGMarketed

Notices of Compliance

NOCDateSubmissionReason
229302019-11-21Abbreviated New Drug Submission (ANDS)
Request a quote for TEVA-LIOTHYRONINE

How to read a Canadian DIN record